Jahr Robert Charles
SEC insider (Form 3/4/5 filer). CIK 0002076177. Chief Executive Officer at Outlook Therapeutics, Inc. (OTLK). 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2026. Located in ISELIN, NJ.
Companies Jahr Robert Charles has filed insider reports for
- Outlook Therapeutics, Inc. (OTLK): Director, Officer, Chief Executive Officer
Jahr Robert Charles
CIK: 0002076177
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OTLK
Outlook Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Aug 14, 2026OTLK
Outlook Therapeutics, Inc.
PurchaseDirect151.5K shares- - Jul 21, 2026OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
100K shares- - Jul 1, 2025OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
800K shares-
1-3 of 3 transactions